NINA VLAINICH: Open Payments
NPI 1467130427 · ALTAMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 40 payments from 10 companies in 2025. Trend: 2023 $795 · 2024 $1,860 · 2025 $1,020
Food & beverage: $912Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $362 |
| E.R. Squibb & Sons, L.L.C. | 10 | $185 |
| Incyte Corporation | 2 | $145 |
| Regeneron Healthcare Solutions, Inc. | 2 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Galderma Laboratories, L.P. | 1 | $40 |
| UCB, Inc. | 1 | $37 |
| GENZYME CORPORATION | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
Products named: SKYRIZI, Sotyktu, OPZELURA, DUPIXENT, Rhapsido, NEMLUVIO, Bimzelx, ILUMYA.
Industry payments across NY — which companies pay providers there.
